SCHEMBL2404155

SCHEMBL2404155

N#Cc1ccc(S(=O)(=O)NC2CCC(C(=O)N3CCNCC3)CC2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.51
HRH2 P25021 2/20 0.48
HRH1 P35367 2/20 0.48
CHRNB2 P17787 1/20 0.48
CHRNA3 P32297 1/20 0.48
CHRNA4 P43681 1/20 0.48
CHRNB3 Q05901 1/20 0.48
CHRNA6 Q15825 1/20 0.48
P4HB P07237 1/20 0.47
SFRP1 Q8N474 1/20 0.46
ALDH1A1 P00352 1/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
KDM1A O60341 1/20 0.44
EPHX2 P34913 1/20 0.43
PAX8 Q06710 1/20 0.42
HPGD P15428 1/20 0.42
HTT P42858 1/20 0.42
CCR6 P51684 1/20 0.41
DPP4 P27487 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2403520 0.85 THRB (0.47) THRBHRH2HRH1P4HBSFRP1
SCHEMBL2402262 0.85 HRH3 (0.53) THRBHRH2HRH1ALDH1A1MEN1
SCHEMBL2402621 0.85 THRB (0.47) THRBHRH2HRH1P4HBALDH1A1
SCHEMBL2401452 0.85 IRAK4 (0.52) THRBHRH2HRH1ALDH1A1MEN1
SCHEMBL2401449 0.85 IRAK4 (0.52) THRBHRH2HRH1ALDH1A1MEN1
SCHEMBL2402269 0.85 HRH3 (0.53) THRBHRH2HRH1ALDH1A1MEN1
SCHEMBL2403518 0.85 THRB (0.47) THRBHRH2HRH1P4HBSFRP1
SCHEMBL2402626 0.85 THRB (0.47) THRBHRH2HRH1P4HBALDH1A1
SCHEMBL2400996 0.84 THRB (0.52) THRBHRH2HRH1P4HBALDH1A1
SCHEMBL2401000 0.84 THRB (0.52) THRBHRH2HRH1P4HBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8017773-B2 Cyclohexyl sulfonamide derivatives HOFFMANN-LA ROCHE INC. (US) 2011-09-13 US disclosed
EP-1979322-B1 CYCLOHEXYL SULFONAMIDE DERIVATIVES HAVING H3 RECEPTOR ACTIVITY HOFFMANN LA ROCHE (CH) 2010-09-01 EP disclosed
US-20100120791-A1 CYCLOHEXYL SULFONAMIDE DERIVATIVES NETTEKOVEN MATTHIAS 2010-05-13 US disclosed
US-20070173511-A1 Cyclohexyl sulfonamide derivatives F. HOFFMANN-LA ROCHE AG (CH) 2007-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120791-A1 CYCLOHEXYL SULFONAMIDE DERIVATIVES HRH3, HRH4, HRH1 THRB 325/4885HRH2 5/4885HRH1 3/4885
US-20070173511-A1 Cyclohexyl sulfonamide derivatives HRH3, HRH4, HRH1 THRB 325/4885HRH2 5/4885HRH1 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.